Durvalumab improves long-term outcome in TNBC: results from the phase II randomized GeparNUEVO study investigating neodjuvant durvalumab in addition to an anthracycline/taxane based neoadjuvant ...

The Health Information Trust Alliance (HITRUST) announced its plans to support the healthcare industry in 2011 and beyond with initiatives aimed at maintaining the comprehensiveness and relevance of ...